Gregory H Merriman

This inventor holds 24 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent, primarily in Heterocyclic Compounds. Top assignees: Hoechst Roussel Pharmaceuticals, Aventis Pharmaceuticals Inc., Hoechst Marion Roussel. Active years: 1994-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory H Merriman. Retrieved from https://idiyas.com/inventor/gregory-h-merriman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 70.8

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.3

ph-index = 6

Forward Citations = 157(Granted Patents)

Location History:

Fairfield, OH (US) (1994 - 1997)
Somerset, NJ (US) (1999 - 2002)
Phillisburg, NJ (US) (2008)
Phillipsburg, NJ (US) (1999 - 2011)

Company Filing History:

11 out of 539

Hoechst Roussel Pharmaceuticals

patents

5 out of 207

Aventis Pharmaceuticals Inc.

patents

4 out of 236

Hoechst Marion Roussel

patents

4. 2 out of 1,855

Sanofi-A Ventis Deutschland Gmbh

patents

5. 1 out of 1

Aventis Hoklings Inc.

patent

6. 1 out of 1

Hoescht Roussel Pharmaceuticals Inc.

patent

Years Active: 1994-2011

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

P2X7 Ion Channel Blockers

Interleukin-4 Inhibitors

Amino Acid Derivatives

Hexahydropyrazino Compounds

Nitrogen-Substituted Derivatives

Isoindolines

Propanediols

Gene Expression Modulators

Medicinal Chemistry

Pharmaceutical Compounds

Chemical Synthesis

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7994168 - Hexahydro-pyrazino[1,2-A]pyrimidine-4,7-dione derivatives substituted with amino acids (2011-08-09),

2. 7741493 - Heterocyclic compounds as P2X7 ion channel blockers (2010-06-22),

3. 7652007 - Nitrogen-substituted hexahydropyrazino[1,2-A]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments (2010-01-26),

4. 7511046 - [object Object] (2009-03-31),

5. 7326792 - Heterocyclic compounds as P2X7 ion channel blockers (2008-02-05),

6. 7169925 - Indole derivatives as interleukin-4 gene expression inhibitors (2007-01-30),

7. 7125903 - [object Object] (2006-10-24),

8. 6500849 - 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino 1,3-propanediols and related compounds (2002-12-31),

9. 6004977 - N-(pyridinylamino) isoindolines and related compounds (1999-12-21),

10. 5977147 - 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino- 1,3-propanediols and (1999-11-02),

11. 5972963 - 3-aryl-2-(1-substituted 4-piperidinyl)-1,1-dioxo-3H-benzo[D]isothiazoles (1999-10-26),

12. 5614631 - 1-alkyl-,1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and (1997-03-25),

13. 5597838 - 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and (1997-01-28),

14. 5574164 - 1-alkyl-,1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and (1996-11-12),

15. 5571923 - 1-Alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and (1996-11-05),

Title: Gregory H Merriman - Pioneering Inventor from Fairfield, OH

Introduction: Gregory H Merriman is a distinguished inventor hailing from Fairfield, Ohio, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Gregory H Merriman holds several patents in the areas of renewable energy technologies, medical devices, and consumer electronics, showcasing his versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Merriman has consistently pushed the boundaries of technological advancement, with his inventions revolutionizing industries and improving the lives of many.

Collaborations: Throughout his career, Gregory H Merriman has collaborated with leading research institutions, universities, and companies to bring his ideas to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Gregory H Merriman's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, leaving a lasting impact on the world of technology and beyond.

Profile summary based on public USPTO records.